Lapchak v. Paradigm Biopharmaceuticals (USA), Inc.

District Court, S.D. California·Decided February 7, 2025·No. 3:24-cv-00143·Unknown

Opinion

PAUL A. LAPCHAK, an individual, Case No.: 24-CV-143 JLS (DDL)

Plaintiff, ORDER GRANTING DEFENDANTS’ v. MOTION TO DISMISS

(ECF No. 9) (USA), INC., a Delaware corporation; and DONNA SKERRETT, an individual, Defendants.

Presently before the Court are Defendants Paradigm Biopharmaceuticals (USA), Inc. (“Paradigm”) and Donna Skerrett’s (“Skerrett”) (collectively, “Defendants”) Motion to Dismiss Plaintiff’s First Amended Complaint’s Second, Third, and Fourth Causes of Action (“Mot.,” ECF No. 9) and Memorandum of Points and Authorities in Support Thereof (“Mem.,” ECF No. 9-1). Plaintiff Paul A. Lapchak filed an Opposition to the Motion (“Opp’n,” ECF No. 11), to which Defendants submitted a Reply (“Reply,” ECF No. 13). The Court took this matter under submission without oral argument pursuant to Civil Local Rule 7.1(d)(1) on June 27, 2024. ECF No. 12. Having carefully considered the Parties’ arguments, Plaintiff’s First Amended Complaint (“FAC,” ECF No. 4), and the law, the Court rules as follows. / / / I. Plaintiff’s Allegations Plaintiff, a San Diego, California resident, is a renowned scientist, with a PhD in Pharmacology. FAC ¶¶ 1, 8. Plaintiff was hired by Paradigm, a New York corporation1 that develops and sells drug formulas, to be its executive, holding the title of “Global Head of Translational Development,” on or about October 7, 2022. Id. ¶¶ 2, 9, 11. Plaintiff alleges Skerrett, a citizen of New York, and Paradigm, were each the “alter ego of the other.” Id. ¶¶ 3, 7. Plaintiff was an executive for approximately 12 months, and his last performance evaluation indicated he “exceeded on all measures of performance.” Id. ¶ 10. On or about October 3, 2023, Paradigm sent Plaintiff a new employment agreement that had not been negotiated with him, and which “materially altered several aspects of the parties’ agreed- upon contractual relationship.” Id. ¶ 12. On or about October 10, 2023, Plaintiff protested the changes and stated he would not enter into the new agreement. Id. ¶ 13. Plaintiff is also a shareholder in Paradigm and shares promised to him have not been timely provided, as set forth in his Employment Agreement. Id. ¶ 14. For example, his “sign on bonus” of 25,000 shares were due October 24, 2022, and were not timely provided. Id. ¶ 15. His one-year anniversary 100,000 shares were due October 24, 2023, and were also not timely provided. Id. ¶ 16. On October 29, 2023, Paradigm issued a “trading halt” and issued a “rights offer” or “entitlement offer” to its employees, and Plaintiff timely exercised his entitlement/rights offer as to the missing 125,000 shares of Paradigm stock. Id. ¶ 17. Plaintiff has not received the 125,000 shares to which he is entitled, nor other shares to which he is entitled under a capital raise. Id. ¶¶ 18, 19. He indicates Skerrett, “is a person responsible for Paradigm’s failure to pay Lapchak wages under California law.” Id. ¶ 25. 1 While Plaintiff alleges Paradigm is a New York corporation, the Court notes the FAC’s caption indicates On November 1, 2023, at a company-wide team meeting, Plaintiff “presented an overview of drug toxicity,” then on November 17, 2023, “presented a power point deck to Paradigm’s safety officer, director of clinical operations, and head of osteoarthritis[,] summarizing significant multi-organ toxicity of Paradigm’s drug product.” Id. ¶ 20. He proceeded to inform the regulatory department of the multi-organ toxicity of the product. Id. Subsequently, purportedly retaliating against Plaintiff’s actions, Defendants disabled Plaintiff’s access to the workplace computers. Id. ¶ 21. After Plaintiff protested, Plaintiff avers Defendants “falsely claimed” Plaintiff was still an employee. Id. ¶ 21. Defendants formally terminated Plaintiff on or about January 12, 2023. Id. ¶ 22. II. Procedural Background Plaintiff filed a Complaint on January 22, 2024. ECF No. 1. After the Parties met and conferred regarding Defendants’ concerns with the Complaint, Plaintiff amended his Complaint to address such concerns and filed his FAC on March 28, 2024. Mem. at 9.2 Defendants, dissatisfied with Plaintiff’s FAC, indicate their counsel made multiple requests for Plaintiff to voluntarily agree to amend his FAC, ultimately resulting in the instant Motion. Id. at 9–10. Plaintiff’s FAC alleges (1) breach of contract against both Defendants; (2) breach of fiduciary duties and violation of California Corporations Code Section 309 against Defendant Skerrett; (3) violation of “California Whistleblower Statute” against both Defendants; (4) and violations of “California Employment Law” against both Defendants. See generally FAC. Rule 12(b)(6) permits a party to raise by motion the defense that the complaint “fail[s] to state a claim upon which relief can be granted.” Fed. R. Civ. P. 12(b)(6). The

Free access — add to your briefcase to read the full text and ask questions with AI

Lapchak v. Paradigm Biopharmaceuticals (USA), Inc., (S.D. Cal. 2025).

Lapchak v. Paradigm Biopharmaceuticals (USA), Inc. (Lapchak v. Paradigm Biopharmaceuticals (USA), Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Destfino v. Reiswig
630 F.3d 952 (Ninth Circuit, 2011)
John Desoto v. Yellow Freight Systems, Inc.
957 F.2d 655 (Ninth Circuit, 1992)
Michael Lacey v. Joseph Arpaio
693 F.3d 896 (Ninth Circuit, 2012)
Tooley v. Donaldson, Lufkin, & Jenrette, Inc.
845 A.2d 1031 (Supreme Court of Delaware, 2004)
Fisher v. San Pedro Peninsula Hospital
214 Cal. App. 3d 590 (California Court of Appeal, 1989)
Patten v. Grant Joint Union High School District
37 Cal. Rptr. 3d 113 (California Court of Appeal, 2005)
Carter v. Escondido Union High School District
56 Cal. Rptr. 3d 262 (California Court of Appeal, 2007)
Morgan v. Regents of the University of California
105 Cal. Rptr. 2d 652 (California Court of Appeal, 2000)
Kramer v. Western Pacific Industries, Inc.
546 A.2d 348 (Supreme Court of Delaware, 1988)
Love v. Motion Industries, Inc.
309 F. Supp. 2d 1128 (N.D. California, 2004)
City of Arcadia v. United States Environmental Protection Agency
265 F. Supp. 2d 1142 (N.D. California, 2003)
Blanche Paylor v. Hartford Fire Insurance Group
748 F.3d 1117 (Eleventh Circuit, 2014)
Miklosy v. Regents of the University of California
188 P.3d 629 (California Supreme Court, 2008)
Bowen v. M. Caratan, Inc.
142 F. Supp. 3d 1007 (E.D. California, 2015)
United States ex rel. Lupo v. Quality Assurance Services, Inc.
242 F. Supp. 3d 1020 (S.D. California, 2017)